Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleIntratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
- Where
- Stanford
- Age
- 18 years and over
- People
- 41
- Run by
- VLP Therapeutics
See details and how to joinNCT06736379 - Phase 1Not yet taking people in United StatesProactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)
- Where
- Houston
- Age
- 18 years and over
- People
- 48
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07832266 - Phase 1/2Taking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Austin, Grand Rapids, Houston, Huntersville, Miami, Minneapolis, Nashville, Salt Lake City, San Antonio, St Louis
- Age
- 18 years and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - Phase 2Taking peoplePembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06161545 - No phaseTaking peopleA Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 10
- Run by
- IBA Proton Therapy, Inc.
See details and how to joinNCT07644585 - No phaseTaking peoplePostoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
- Where
- Charlotte, Milwaukee, Winston-Salem
- Age
- 18 years and over
- People
- 75
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06607406 - No phaseTaking peopleMultidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 1,000
- Run by
- Stanford University
See details and how to joinNCT05880797 - No phaseTaking peopleFatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- Where
- San Francisco
- Age
- 18 years and over
- People
- 125
- Run by
- University of California, San Francisco
See details and how to joinNCT06633224 - Phase 2Taking peopleEffects of Infusion Timing on Treatment Response in Solid Tumors
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 238
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07630168 - Phase 1/2Not yet taking people in United StatesA Study of IOV-5001 in Adults With Advanced Solid Tumors
- Where
- New York
- Age
- 18 years to 70 years
- People
- 106
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT07743723 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Appleton, Aurora, Birmingham, Boston, Broomall, Chandler, Chapel Hill, Cincinnati, Cleveland, Dallas, East Brunswick, Edinburg, Forth Worth, Grand Rapids, Hollywood, Hot Springs, La Jolla, Lakeland, Lewiston, Myrtle Beach, New Orleans, Newport Beach, New York, Philadelphia, Redwood City, Rochester, Rock Hill, Sacramento, Salt Lake City, San Antonio, Shreveport, Toledo, York
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Phase 2Taking peopleOmission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
- Where
- Charleston
- Age
- 18 years and over
- People
- 36
- Run by
- Medical University of South Carolina
See details and how to joinNCT07513389 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Baltimore, Columbus, Los Angeles, New York, Philadelphia, Stony Brook
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - Phase 1/2Taking peopleFirst in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Where
- Austin, Boston, Cleveland, Columbus, Irving, Miami, New Haven, New York, Rochester, San Antonio, Seattle, St Louis
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06657222 · EU 2025-522517-35-00 - No phaseTaking peopleExercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
- Where
- Sacramento
- Age
- 18 years and over
- People
- 20
- Run by
- University of California, Davis
See details and how to joinNCT06722508 - Phase 1Taking peopleADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
- Where
- Boston, Houston, New Haven, New York, Rogers, San Antonio, St Louis
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Adcendo ApS
See details and how to joinNCT06597721 - No phaseTaking peopleBuilding a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
- Where
- Charleston, Dallas, Detroit, Hershey, St Louis
- Age
- 18 years and over
- People
- 180
- Run by
- Medical University of South Carolina
See details and how to joinNCT05442957 - No phaseTaking peopleA Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Where
- Appleton, Atlanta, Baltimore, Boston, Chicago, Cincinnati, Cleveland, Columbus, Decatur, Detriot, Detroit, Duarte, Fargo, Jacksonville, Los Angeles, Nashville, New York, Palo Alto, Peoria, Philadelphia, Rochester, Santa Rosa, Seattle, Sioux Falls, Springfield, St Louis, Westwood, York
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Tempus AI
See details and how to joinNCT06163534 - Phase 1/2Taking peopleA Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Where
- Buffalo, Fort Worth, Indianapolis, Lake Success, Los Angeles, Sarasota
- Age
- 18 years and over
- People
- 132
- Run by
- InduPro, Inc.
See details and how to joinNCT07602842 - Phase 2Taking peopleAtorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- Where
- Atlanta, Baltimore, Bethesda, Fairfax, Rochester
- Age
- 18 years to 100 years
- People
- 224
- Run by
- National Institute on Deafness and Other Communication Disorders (NIDCD)
See details and how to joinNCT04915183 - Phase 2Taking peopleEfficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
- Where
- Manhattan, New Haven
- Age
- 18 years and over
- People
- 30
- Run by
- VSPharmTech Co.,Ltd.
See details and how to joinNCT06959082 - Phase 1Taking peopleFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Where
- Houston, La Jolla, Los Angeles, Minneapolis, Philadelphia
- Age
- 18 years and over
- People
- 119
- Run by
- Fate Therapeutics
See details and how to joinNCT07216105 - No phaseTaking peoplePrehabilitation Protocol for Head and Neck Cancer Patients
- Where
- Miami
- Age
- 18 years to 80 years
- People
- 60
- Run by
- University of Miami
See details and how to joinNCT07318220 - No phaseNot yet taking people in United StatesPrognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT07797738 - Phase 1/2Not yet taking people in United StatesRandomized Clinical Trial of the Application of TrachPhone HME and the Impact on Patient Satisfaction for Tracheostomized Head and Neck Cancer Patients
- Where
- Tampa
- Age
- 18 years and over
- People
- 80
- Run by
- University of South Florida
See details and how to joinNCT07798414